Ertugrul, D. T. Et Al. 2022. Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes. International Journal of Diabetes in Developing Countries , vol.42, no.1 , 147-160.

Ertugrul, D. T., Kan, E., Tura, C. B., Tugtekin, H. B., Ayakta, H., Celebioglu, M., ... Yilmaz, C.(2022). Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes. International Journal of Diabetes in Developing Countries , vol.42, no.1, 147-160.

Ertugrul, MUSTAFA Et Al. "Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes," International Journal of Diabetes in Developing Countries , vol.42, no.1, 147-160, 2022

Ertugrul, MUSTAFA Et Al. "Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes." International Journal of Diabetes in Developing Countries , vol.42, no.1, pp.147-160, 2022

Ertugrul, D. T. Et Al. (2022) . "Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes." International Journal of Diabetes in Developing Countries , vol.42, no.1, pp.147-160.

@article{article, author={MUSTAFA AYDEMİR Et Al. }, title={Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes}, journal={International Journal of Diabetes in Developing Countries}, year=2022, pages={147-160} }